QR-koda

Alternative consent methods used in the multinational, pragmatic, randomised clinical trial SafeBoosC-III

Abstract Background The process of obtaining prior informed consent for experimental treatment does not fit well into the clinical reality of acute and intensive care. The therapeutic window of interventions is often short, which may reduce the validity of the consent and the rate of enrolled partic...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Váldodahkkit: Maria Linander Vestager, Mathias Lühr Hansen, Gorm Greisen, the SafeBoosC-III trial group
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: BMC 2024-04-01
Ráidu:Trials
Fáttát:
Liŋkkat:https://doi.org/10.1186/s13063-024-08074-0
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!